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WHAT THIS PAPER ADDS
The use of chimney and periscope grafts for the treatment of aneurysms involving the supra-aortic branches is
reported with mid-term follow-up. This tool uses off the shelf devices and it can be employed in the emergency
setting. This single centre experience reports the use of self expandable covered stents for parallel graft con-
struction with particular attention to a standardised technique. The limited experience and follow-up available
allow the use of this technique in high risk patients unﬁt for conventional surgery.
Purpose: Report mid-term outcomes of thoracic endovascular aneurysm repair (TEVAR) with chimney and
periscope grafts (CPG) in supra-aortic branches (SAB).
Methods: Retrospective analysis, from October 2009 to May 2014, of patients with aneurysms requiring TEVAR
with zone 0/1/2 proximal landing in association with at least one CPG in the SAB. All patients were considered at
high risk for conventional surgery. Peri-operative mortality and morbidity, retrograde type A dissection, maximum
aortic transverse diameter (TD) and its post-operative evolution, endoleak, survival, freedom from cardiovascular
re-interventions, and CPG freedom from occlusion during the follow-up were analysed.
Results: Forty-one patients (28.05% EuroScore II) with thoraco-abdominal aortic aneurysm (17%), arch aneurysm
(39%), descending aneurysm (34%), and aneurysm extending from the arch to the visceral aorta (10%) were
included. Fifteen (37%) patients were treated non-electively. Fifty-nine SABs were treated with the CPG
technique: one, two, three, and four CPG were employed in 71%, 19%, 5%, and 5% of patients, respectively. The
proximal landing was in zone 0 in 49% of patients, zone 1 in 17%, and zone 2 in 34%. Technical success was 95%.
Peri-operative complications and neurological events were registered in six (14.6%) patients and there were 5
deaths (12%). At a median follow-up of 21.2 (mean 22, SD 18; range 0e65) months, type I/III endoleaks were
registered in three (7%) cases and re-intervention in six (15%) patients. A signiﬁcant aneurysm sac shrinkage
(p<.001) was reported at mean follow-up and no signiﬁcant aneurysm sac increase (>5 mm). The estimated 2
year survival, freedom from re-intervention, freedom from endoleak, and freedom from branch occlusion were
75%, 77%, 86%, and 96%, respectively.
Conclusion: The chimney and periscope grafts technique was shown to be safe in aortic aneurysm disease
involving the supra aortic branches, even in an emergency setting using off the shelf devices. Mid-term follow-up
results in this high risk population are good, but longer follow-up is mandatory before this technique is used in
intermediate-risk patients.
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INTRODUCTION
Thoracic endovascular aortic repair (TEVAR) is the ﬁrst line
approach for the treatment of aortic disease involving the
descending thoracic aorta with reduced mortality and
morbidity rates compared with conventional surgery.1
* Corresponding author. Via Liborio Giuffrè, 5, Palermo 90100, Italy.
E-mail addresses: felicepecoraro@libero.it; felice.pecoraro@unipa.it
(F. Pecoraro).
1078-5884/ 2017 European Society for Vascular Surgery. Published by
Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejvs.2017.06.014
Eur J Vasc Endovasc Surg (2017) 54, 295e302
Aneurysm extension over supra-aortic branches (SAB) still
represents a limitation to standard TEVAR. Fenestrated and
branched devices have been introducedwith promising results
in the elective setting to overcome such limitations.2 Also
chimney and periscope grafts (CPG) in the SAB have been re-
ported, but experience and follow-up is generally very limited.
Herein, mid-term experience with this technique is reported.
METHOD
From October 2009 to May 2014, data from patients treated
with CPG in the SAB were collected in the clinical information
system of the University Hospital of Zurich (KISIM 4.901;
Dendrite, Dendrite Clinical System, Henley-on-Thames, UK).
Indications for treatment were aneurysmal aortic disease
(ascending, arch or descending) requiring TEVAR proximal
landing in zone 0, 1, or 2 in associationwith at least one CPG in
the SAB. All patients were considered high risk for conven-
tional surgery. The high risk proﬁle for conventional surgery
(graft replacement) with a Euroscore II >5% and/or pre-
senting multifocal aneurysm locations was deﬁned according
to Andersen et al., including comorbidities (age >65 years,
coronary artery disease, heart failure, chronic obstructive
disease, and impaired renal function) and anatomical char-
acteristics (thoraco-sternotomy incision and two stage open
repair).3 At the study institution there is a policy for high risk
patients unﬁt for conventional surgery with a life expectancy
more than 2 years. In younger/ﬁtter patients, SAB rerouting in
association with standard TEVAR is the preferred choice. In
more frail patients a total endovascular solution is preferred
with adequate anatomy. Surgical and endovascular solutions
for SABs were combined in cases of anatomical challenge.
Interventions were planned on CT angiography in all patients.
Demographic and clinical data were collected including
the NSQIP4 and the EuroSCORE II risk model.5 The New York
Heart Association (NYHA) heart function6 and the Global
Initiative for Chronic Obstructive Lung Disease (GOLD)7
were employed to assess cardiac and respiratory function.
The study was approved by the local ethics committee and
all patients gave informed consent for the procedure itself
and the anonymous data collection and analysis. Earlier
data with shorter follow-up for 29 of these patients have
been published previously inside a multicentre study.8
Technical successwas deﬁned according to TEVAR reporting
standards.9 Outcomes measured included peri-operative
mortality and morbidity, retrograde type A dissection,
maximumaortic TD and aneurysmvolumewith post-operative
evolution, endoleak, survival, freedom from re-interventions,
and freedom from CPG occlusion during the follow-up.
Follow-up consisted of clinical examination and CTA
performed at 3, 6, and 12 months, and annually thereafter.
CTA was performed with low dose contrast (40cc) and, to
protect renal function, patients were generously hydrated
intravenously pre and post CTA. Patients with renal function
impairment were followed with non-contrast computed
tomography and duplex ultrasound (DUS) imaging of the
aorta and target vessels. For endoleak with a stable or
reduced aneurysm sac, follow-up with clinical examination,
CTA, and echocardiography was repeated every 6 months.
For increasing sac size, imaging follow-up was performed
within 3 months and if growth was detected a redo pro-
cedure was performed. Median follow-up was 21.2 (mean
22, SD 18; range 0e65) months.
Statistical analysis
Means and standard deviation (SD) ormedian and rangewere
reported for parametric data; absolute values and percent-
ages for non-parametric data. Differences in pre-operative
and post-operative maximum aortic TD were assessed using
the t test. KaplaneMeier curves were used to estimate sur-
vival and freedom from cardiovascular re-intervention. Sta-
tistical signiﬁcance was considered at p < .05. For Kaplane
Meier curves, conﬁdence intervals (CI) and standard error
exceeding 10% were reported. Statistical analysis was per-
formed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA).
Technique
Procedures were performed in a dedicated angio-suite
(Artiszeego; Siemens AG, Forchheim, Germany) or in a
hybrid room (Philips Medical Systems, Inc., Shelton, CT,
USA) in 31% and 69%, respectively, of cases.
As reported, accesses were selected according to the
anatomy and the intention to address SABs according to the
proximal landing zone.10 For chimney conﬁguration access
was performed with consideration of the target vessel. For
the brachiocephalic trunk (BCT), access was generally per-
formed percutaneously from the right axillary/brachial ar-
tery. Alternatively, surgical access via the right carotid artery
(RCA) was employed. The left carotid artery (LCA) was
accessed via surgical access and the left subclavian artery
(LSA) via percutaneous axillary/brachial access.
For periscope conﬁguration access was via the femoral
artery (surgical or percutaneous).11,12 All percutaneous ac-
cesses were performed with the preclosure technique
(Proglide, Abbott Vascular, Redwood City, CA, USA),13 under
DUS imaging. Axillary percutaneous access was performed
using the micropuncture technique to reduce the risk of
nerve or plexus damage.14
For the chimney conﬁguration, after gaining access to the
target vessel, a standard wire (Boston Scientiﬁc, Natick, MA,
USA) was inserted and placed in the ascending aorta. For the
periscope conﬁguration, the SABs were engaged from the
femoral access with a long introducer sheath. Before sheath
introduction, 5000 units of heparin were ﬁrst administered.
Heparin administration was then modulated to maintain an
activated clotting time> 300 s to reduce the risk of thrombus
generation and cerebral events while wire, catheters, and
stent grafts were parked in the ascending aorta and/or aortic
arch. In addition, patients were kept in the Trendelenburg
position during aortic stent graft deployment to reduce the
risk of brain air embolism. For both the chimney and peri-
scope conﬁgurations a stent graft (Hemobahn or Viabahn;
W.L. Gore & Associates, Flagstaff, AZ, USA) was positioned in
the target SAB over a Rosen (Cook Medical, IN, USA) or
Amplatz (Boston Scientiﬁc) wire with the support of a sheath.
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The aortic stent graft was then introduced and positioned at
the intended proximal landing zone (TAG; W.L. Gore & As-
sociates). Generally, ﬁrst the CPG stent grafts, then the aortic
stent graft were deployed. During the procedure, systolic
blood pressure was mostly maintained at about 100e
120 mmHg. When landing an aortic stent graft in zone 0, a
short period of slight hypotension with systolic pressure
around 100 mmHg was induced with short acting vasodila-
tors. For long descending aorta coverage, the systolic blood
pressure was maintained > 120 mmHg.
After deployment of the CPGs, sheaths were reinserted
for stabilisation and for eventual proximal and/or distal
stent graft extension. The aortic stent graft was parked and
deployed approximately 1 cm distal to the CPG position.
CPGs were oversized 1e2 mm with respect to the target
SAB.The aortic stent graft was sized according to the formula:
mean aortic diameter at landing zoneþ half the diameter of
each CPG used. A minimum of 2 cm overlapping between the
aortic and the CPG stent graft was required at the proximal/
distal landing zones. Proximal landing zone and adequate
(>2 cm) overlapping were identiﬁed pre-operatively from
the CTA.These data were conﬁrmed during the positioning of
the CPG and aortic stent graft before deployment (Fig. 1).
When more thoracic stent grafts were required to cover long
aortic segments (i.e. Crawford II or III thoraco-abdominal
aortic aneurysm [TAAA]), connection was performed with a
sequential distal to proximal deployment. The overlap be-
tween stent grafts was about 5 cm; in very angulated aortas
or when aortic stent grafts were of similar diameter, longer
overlapping was preferred. The CPGs and the aortic stent
graft were moulded using the kissing balloon technique.
Moulding of the stent grafts was performed using cor-
responding PTA balloons for the CPGs and the Reliant
balloon (Medtronic, Santa Rosa, USA). To avoid aortic wall
stress and minimise the risk of aortic dissection, the aortic
stent graft and CPG were moulded sequentially in zone
0 and great care was taken to ensure that the Reliant
balloon did not extend into the native aorta.
Intra-operative arterial pressure measurements were
made in all vessels treated with a CPG and in the aorta (at
the junction between the stent graft and the native vessel).
A mean pressure drop > 20% was considered to be a cutoff
for additional CPG and/or thoracic stent graft ballooning. A
ﬁnal angiogram was performed to complete the procedure
(Fig. 2). Since 2015 all parallel grafts have been primarily
reinforced by a corresponding Wallstent (Boston Scientiﬁc)
relining the entire length over which the CPG could be
compressed when running parallel to the aorta.
For TAAA, to reduce the risk of spinal hypoperfusion, the
systolic blood pressure was maintained between 120 and
150 mmHg throughout the procedure and for 6 weeks after
intervention. For spinal cord symptoms, a 50 mL bolus of
mannitol 20% was given and repeated every 2e4 hours. In
addition, a bolus of hydrocortisone was given intravenously.
Patients with spinal cord ischaemia symptoms were trans-
ferred to the ICU for blood pressure (systolic pressure
>140 mmHg; mean arterial pressure 70e90 mmHg) and
haematocrit optimisation (>30%).10 Post-operative medi-
cation consisted of 100 mg aspirin daily and therapeutic
heparinisation during hospitalisation. At discharge, patients
were switched to dual antiplatelet therapy (100 mg aspirin
and 75 mg clopidogrel per day).
All patients underwent CTA before discharge (Fig. 3).
Follow-up was performed according to the reported
protocol.
RESULTS
Forty-one patients were included, with a mean age of 68.03
(SD 13; range 27e87) years, with a mean pre-operative
NSQIP and EuroScore II of 14.23% (SD 8; range 11e18)
and 28.05% (SD 14; 22e34), respectively. During the same
period, a surgical SAB debranching procedure was per-
formed in 38 patients. Comorbidities and risk factors are
reported in Table 1.
The indication for CPG treatment was a TAAA in seven
(17%) cases, an arch aneurysm in 16 (39%); a descending
aneurysm in 14 (34%); and an aneurysm extending from
arch to the visceral aorta in the remaining four (10%) pa-
tients. Of the seven TAAA, two were Crawford type I, three
Crawford type II, one Crawford III, and one Crawford IV. In
14 (34%) cases there was associated type B dissection.
Twenty-six (63%) patients were treated electively and 15
(37%) non-electively. Aneurysm symptoms were reported in
six patients (15%), and rupture in nine patients (22%). In 11
(27%) cases, an open debranching of 26 SABs was required
before the CPG treatment. In six patients, left carotid to left
subclavian artery debranching was also performed. In
addition six (15%) patients required open visceral
debranching and six (15%) CPG to visceral arteries before
the main procedure. Open debranching of SABs was indi-
cated in patients presenting endovascular challenges
including shaggy aorta and/or signiﬁcant atherosclerotic
deposits in aortic branches or dissected stem and/or severe
kinking of aortic branches, to reduce potential procedural
complication of EVAR. The mean pre-operative maximum
Figure 1. Three dimensional CT angiography volume rendering
showing an arch aneurysm involving the supra-aortic branches.
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transverse aortic diameter and aneurysm volume were
61.38 (SD 17, 26e100) mm and 416 (SD 531, 43e2670) mL,
respectively.
A total of 59 SABs were treated by the CPG technique
(mean of 1.4 vessels per patient). No signiﬁcant differences
were observed for the number of SABs treated in elective
and non-elective cases (40/26 vs. 59/15; p¼.24). In 29 cases
a single CPG was used, in eight a double, in two a triple, and
in four a quadruple. The chimney conﬁguration was
employed in 30 (51%) vessels and the periscope conﬁgu-
ration in 29 (49%). Eight (14%) brachiocephalic trunks (BCT),
six (10%) right carotid arteries (RCA), 15 (25%) left carotid
arteries (LCA), and 30 (51%) left subclavian arteries (LSA)
were treated using the CPG technique. Self expandable
stent grafts were used in all vessels. These were relined with
self expandable uncovered stents in 26/59 (44%) SABs.
According to the Ishimaru classiﬁcation,15 the thoracic
stent graft proximal landing zone was in zone 0 in 20 (49%)
patients, zone 1 in seven (17%) patients, and zone 2 in 14
(34%) patients. In all cases the TAG (W.L. Gore & Associates)
thoracic stent graft was employed for TEVAR.
Technical success was achieved in all but two cases
(95%). Peri-operatively, ﬁve (12%) deaths occurred. Two
Figure 3. Three dimensional CT angiography volume rendering
showing patency of the chimney grafts to the brachiocephalic
trunk and the left carotid artery and the periscope graft to the left
subclavian artery.
Table 1. Demographic and pre-operative clinical data.
Number of patients 41
Mean age, years 68
Over 70 years (%) 21 (51)
Female (%) 14 (34)
Hypertension (%) 37 (90)
Chronic obstructive pulmonary disease (%) 29 (71)
GFR <60 14 (34)
Dialysis 2 (5)
GOLD 1 (%) 4 (10)
GOLD 2 (%) 8 (20)
GOLD 3 (%) 26 (63)
GOLD 4 (%) 3 (7)
Cardiac disease, (%) 28 (68)
Myocardial infarction <6 months (%) 6 (15)
Coronary artery disease (%) 22 (54)
NYHA I (%) 7 (17)
NYHA II (%) 13 (32)
NYHA III (%) 16 (39)
NYHA IV (%) 5 (12)
Lipid disorder (%) 17 (42)
Peripheral arterial disease (%) 10 (24)
Cancer (%) 6 (23)
Cerebral vascular disease (%) 18 (44)
Hostile chest (%) 21 (51)
Previous heart/aortic intervention
Open surgery (%) 23 (34)
Endovascular surgery (%) 10 (15)
Elective repair 26 (63)
Non-elective repair 15 (37)
Pre-operative NSQIP
Pre-operative EUROSCORE II 28.05
GOLD ¼ Global Initiative for Chronic Obstructive Lung Disease;
NYHA ¼ New York Heart Association.
Figure 2. (A) Intra-operative view of a triple supra-aortic chimney and periscope graft. The chimney conﬁguration was used for the
brachiocephalic trunk and the left carotid artery. The periscope conﬁguration was used for the left subclavian artery. Note the overlapping
between the aortic stent graft and the chimney and periscope grafts. (B) Intra-operative arteriogram. Early phase after contrast injection
showing patency of the chimney grafts to the brachiocephalic trunk and the left carotid artery. (C) Intra-operative arteriogram. Later phase
(about 1 s) after contrast injection showing patency of the periscope graft to the left subclavian artery and the chimney grafts.
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patients died intra-operatively because of massive cardiac
tamponade during zone 0 TEVAR. The other deaths
occurred on the second post-operative day (POD), the result
of retrograde type A dissection; on POD 5 from multiorgan
failure; and POD 21 from a stroke. Two deaths occurred in
patients treated non-electively (3/26 [11.5%] deaths in
elective cases and 2/15 [13.3%] deaths in non elective
cases; p¼.87).
Overall, peri-operative complications and neurological
events were registered in six (14.7%) patients. Peri-operative
complications were registered in three (7%) patients (2
elective and 1 non-elective case) and consisted of retrograde
type A dissection in one case, respiratory insufﬁciency in one
case, and myocardial infarction in one case. Another three
(7%) patients (1 elective and 2 non-elective) had peri-
operative neurological complications including stroke in
one, spinal cord ischaemia in one, and stroke with spinal cord
ischaemia in one; these neurological complications occurred
in patients treated with single LSA CPG (1), double LSA and
LCA CPG (1), and four CPGs (1), respectively.
In this series 28 patients were followed for at least 12
months and 18 patients for 24 months. No patients were
lost during follow-up.
During follow-up a type I/III endoleak was registered in
three (7%) cases (2 elective and 1 non-elective) consisting
of one type Ia, one type Ib, and one type III. In addition, a
type II endoleak was registered in three (7%) cases. A re-
intervention was required in 6/41 (15%) patients: because
of coil embolisation (2 patients for a type II and a type Ib
endoleak); a redo TEVAR for a type III endoleak (1); LSA
periscope graft stenting (1); aortic valve replacement for a
retrograde type A dissection; and conﬁguration change
from chimney to periscope (1 patient because the chimney
graft was too long) (Fig. 4). No signiﬁcant differences in the
number of re-interventions in elective and non-elective
cases (15% vs. 13%; p¼.89) were observed. The mean
time to re-intervention was 2.22 (SD 3, 0e15) months. The
aneurysm sac at mean follow-up was 55.34 (SD 17, 26e94)
mm with signiﬁcant aneurysm sac shrinkage (p<.001).
Aneurysm volume at mean follow-up was 324 (SD 381, 26e
2026) mL with a signiﬁcant reduction (p¼.042). No signiﬁ-
cant aneurysm sac increase was seen. In 17 patients sig-
niﬁcant aneurysm shrinkage was reported, and in the
remaining 24 no signiﬁcant difference was reported
compared with baseline measurements.
The estimated survival at 12 and 24 months was 78% and
75%, respectively (SE 4.3, CI 41%e58%). The freedom from
re-intervention at 12 and 24 months was 81% and 77%,
respectively (SE 5.3, CI 37%e58%). The estimated freedom
from endoleak at 12 and 24 months was 94% and 86%,
respectively (SE 4.7, CI 44%e62%). The estimated freedom
from occlusion at 12 and 24 months was 96% (SE 1.7, CI
60%e67%) (Fig. 5).
DISCUSSION
Open surgical treatment of aortic diseases involving SABs is
still the gold standard,1 and it can be carried out with cir-
culatory arrest, cardioplegia, cardiopulmonary bypass, and
moderate or deep hypothermia.16 However, considerable
mortality and neurological event rates of up to 29% and
18% respectively, have been reported for these procedures.
Moreover, worse outcomes were reported in high risk
patients.17,18
Hybrid treatment with supra-aortic debranching has been
proposed in high risk patients, unﬁt for conventional sur-
gery, to reduce the invasiveness of the conventional treat-
ment. The peri-operative outcomes reported are
encouraging, with reported mortality and neurological
event rates of 11.9% and 7.6%, respectively.19
The hybrid approach was reported in combination with
ascending wrapping in cases with no adequate zone
0 proximal landing, with promising results.20,21 The advan-
tage of hybrid repair is that it can be performed off-pump.
However, both conventional and hybrid repairs do require
at least a median sternotomy.
In very-high risk patients,3,22 as reported in this study (pre-
operative NSQIP and EuroScore II of 14.23% and 28.05%), all
patients were considered by the cardiovascular board to be
unﬁt for conventional surgery and hybrid repair. In these
circumstances a total endovascular solution to address the
aortic arch and the SABs is a reasonable alternative.
Fenestrated and branched devices are currently under
investigation with promising short-term results. In a recent
series, 27 patients with arch aneurysm were treated with an
inner branched endograft to maintain blood ﬂow to the BCT
and/or LCA. In that series, 100% technical success and no
peri-operative mortality was reported. Cumulative neuro-
logical events were reported in 5/27 patients (18.5%; 2
major strokes, 1 minor stroke, and 2 transient spinal cord
ischaemia). An early (<30 days) re-intervention was
Figure 4. (A) Plain CT showing a chimney in the left subclavian artery in contact with the ascending aorta. (B) Intra-operative view of the
conﬁguration change from chimney to periscope. (C) Plain CT after conﬁguration change.
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required in four patients (14.8%). Endoleak incidence was
11.1% (3 type II). During the mean follow-up of 12 months
another two re-interventions were required.2
Clearly, the use of such customised devices does not ﬁt in
the emergency setting as reported for CPGs.23 When the
device is required to land in zone 2, a total endovascular
solution with a single CPG graft in LSA in periscope
conﬁguration can be employed with no need for carotid to
subclavian bypass.11
The reported experience with CPGs includes 37% of cases
treated in an emergency setting with a global reported
mortality rate of 12% and a zone 0 proximal landing in 20/
41 (49%) cases. Although it can be argued that use of CPG in
the carotid arteries or BCT increases the risk of cerebral
neurological complications, these were reported in only two
cases treated with a single and a fourfold CPG. By contrast,
spinal cord complications appear to be dependent on the
length of aortic coverage rather than the number of CPGs.
SAB debranching has been performed in some patients to
facilitate the proximal landing zone, in cases of borderline
ascending or arch diameter (35e38 mm). In such cases
using two CPGs in the proximal landing zone was expected
to generate gutter endoleak(s), despite use of the largest
TAG (45 mm). In addition, SAB debranching has been per-
formed in patients with atherosclerotic plaques in the arch
and/or branch(es), branch vessel dissection, or severe kink
of the SAB. It can be argued that SAB debranching com-
bined with CPG procedure reduced the operative time of
both procedures, wire manipulation during the CPG oper-
ation, and the risk of gutter endoleak. Endoleaks have been
recognised as the major Achilles heel of the CPG technique
because of channel gutters resulting from the apposition
between the aortic stent graft and the CPGs. In this situa-
tion creating a sealing zone of more than 2 cm was iden-
tiﬁed as a means of decreasing the incidence of
endoleak.24,25 When the proximal landing is in zone 1 or 2, a
sealing zone of more than 2 cm is mostly achieved using a
periscope conﬁguration. The advantages of landing proxi-
mally in zone 1 are that neither the BCT nor the ascending
aorta is involved.
In this series a type I endoleak was reported in two (5%)
cases; in one patient the endoleak was treated by coil
embolisation, and in the other it resolved spontaneously
during follow-up. There were no ‘slow ﬂow’ or gutter
endoleaks.26 In this experience, the CPG were constructed
exclusively with SECS and used with the TAG (W.L. Gore &
Figure 5. (A) Survival function. Standard error (SE) does not exceed 10% at 24 months (SE 4.3, CI 41e58). (B) Freedom from re-intervention
function. SE does not exceed 10% at 24 months (SE 5.3, CI 37e58). (C) Freedom from type I/III endoleak function. SE does not exceed 10%
at 24 months (SE 4.7, CI 44e62). (D) Freedom from occlusion function. SE does not exceed 10% at 24 months (SE 1.7, CI 60e67).
300 F. Pecoraro et al.
Associates) with the incidence of type I endoleak compa-
rable with previous reports. A recent European experience
of CPGs in SAB showed similar outcomes: the reported peri-
operative mortality, endoleak incidence, and neurological
events were 9.5%, 10.5%, and 2%, respectively, in a cohort
of 95 patients.8 The retrospective analysis, the inclusion of
different types of aortic disease, and the lack of a com-
parison group represent study limitations.
CONCLUSION
In selected patients unﬁt for conventional open aortic arch
repair, a parallel graft technique using self expandable
covered stent grafts as periscopes and/or chimneys to
maintain branch perfusion is a safe treatment option. This
holds true even in the emergency setting, where use of off
the shelf devices allows fast track repair. Short- and mid-
term follow-up show outcomes similar to other repair
techniques.
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Vertebral Penetration of an Inferior Vena Cava Filter
S. Regus *, W. Lang
Department of Vascular Surgery, University Hospital Erlangen, Erlangen, Germany
A 72 year old female underwent retrievable inferior vena cava ﬁlter (IVCF) implantation following a deep vein thrombosis
complicated by pulmonary artery embolism. However, ten years later, a computed tomography scan for a suspected
diagnosis of pneumonia showed the IVCF was penetrating the caval wall (A) and even the vertebral body (A, B).
Interventional removal of the IVCF was not considered feasible given the extracaval IVCF protrusion with bony implantation;
furthermore, given the high risk of major complications open repair was not possible either and the IVCF was left in place.
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